Sponsors (38)
The bill prioritizes a comprehensive, evidence-based National Academies study to guide preterm birth policy and research (potentially improving outcomes and long-term costs), at the cost of upfront federal spending, potential data-privacy risks, and a two-year delay before actionable recommendations are delivered.
State and federal health agencies, hospitals, and policymakers will get a consensus National Academies report that synthesizes costs, drivers, and best practices, enabling more evidence-based policy and program funding decisions.
Pregnant people and families will benefit from a renewed federal focus on preterm birth research and prevention, which could improve maternal and newborn outcomes and reduce NICU stays.
Researchers' work on targeted interventions and precision medicine could identify effective treatments to reduce preterm births, lowering long-term health and financial burdens for affected families and children.
Pregnant people and families affected by preterm birth risk may face delayed improvements because the bill commissions a 24-month study before delivering policy recommendations.
Taxpayers could see increased federal spending because the bill extends authorization and funds a 24-month National Academies study without guaranteed immediate service changes.
Patients and families could face privacy risks if raw data are released without sufficient de-identification or safeguards, potentially exposing confidential health information.
Based on analysis of 2 sections of legislative text.
Introduced February 11, 2025 by Robin L. Kelly · Last progress February 11, 2025
Extends the statutory reauthorization period for the PREEMIE program through fiscal years 2025–2029, corrects a prior technical cross-reference, revises statutory language about the interagency working group, and directs the Department of Health and Human Services to contract with the National Academies to convene an expert committee to study preterm births. The Academies must form the committee within 30 days of enactment and deliver a consensus report (including underlying data) to HHS and specified Congressional committees within 24 months.